rxstat › Shortages › Alglucosidase Alfa

Alglucosidase Alfa (Myozyme) shortage status

Shortage anticipated

Source: Health Canada shortage reports · Updated Jul 29, 2026

A shortage of Alglucosidase Alfa is anticipated but not yet confirmed. 1 product(s) have anticipated-shortage reports on file with Health Canada.
Products affected
0 / 1
Reports on file
2

Reports by product

The DIN is printed on your prescription label.

Anticipated
MYOZYME
50MG · POWDER FOR SOLUTION · SANOFI-AVENTIS CANADA INC
DIN 02284863 · Requirements related to complying with good manufacturing practices.
Resolved
MYOZYME
50MG · POWDER FOR SOLUTION · SANOFI GENZYME, A DIVISION OF SANOFI-AVENTIS CANADA INC
DIN 02284863 · ended Dec 6, 2022 · Demand increase for the drug.

What's happening

A manufacturer has told Health Canada it expects supply of Alglucosidase Alfa to fall short of demand. Anticipated shortages sometimes resolve without patients noticing; this page updates as soon as the status changes.

Alglucosidase Alfa is classified under “OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS” (ATC A16AB).

Recent changes

Common questions

When will Alglucosidase Alfa be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Alglucosidase Alfa in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Possible alternatives in the same class (other alimentary tract and metabolism products)

Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.

Betaine (Cystadane) No current shortage Miglustat (Zavesca) No current shortage Nitisinone No current shortage Avalglucosidase Alfa (Nexviazyme) Partial shortage 1 of 1 reported products affected · est. return Aug 25, 2026 Sapropterin Dihydrochloride (Kuvan) Discontinued 0 of 1 reported products affected Taliglucerase Alfa (Elelyso) Discontinued 0 of 1 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.